February 2026
1. WANG Q, Xu P, Chen J, Yang S, et al
   Serglycin Drives LAG3+ Treg Differentiation and Immunosuppression in Gastric Cancer.
   Cancer Res. 2026 Feb 24. doi: 10.1158/0008-5472.CAN-25-3071.
   

   >> Share

   
   
2. LU Y, Wu X, Li B, Yao L, et al
   GAL3ST1-Mediated Histone Tyrosine Sulfation Induced by Cancer-Associated Fibroblasts Promotes Gastric Cancer Metastasis.
   Cancer Res. 2026 Feb 13. doi: 10.1158/0008-5472.CAN-25-2452.
   

   >> Share

   
   January 2026
3. LIU X, Chen B, Xie F, Wong KY, et al
   Correction: FOXP4 Is a Direct YAP1 Target That Promotes Gastric Cancer Stemness and Drives Metastasis.
   Cancer Res. 2026;86:556.
   

   >> Share

   
   
4. QIN ZY, Che LR, Tian S, Li X, et al
   TRIM49 Deficiency Stabilizes a Galectin-3/EGR1 Transcriptional Complex That Drives Invasiveness of Gastric Adenocarcinoma.
   Cancer Res. 2026;86:402-420.
   

   >> Share

   
   
5. LIAO F, Tong Y, Sun H, Chen S, et al
   Nerves Stimulates Crosstalk between Gastric Cancer and Group 3 Innate Lymphoid Cells to Enhance Immunosuppression.
   Cancer Res. 2026 Jan 14. doi: 10.1158/0008-5472.CAN-25-3092.
   

   >> Share

   
   October 2025
6. WU W, Xun Z, Han Y, Chen Q, et al
   Artificial Intelligence and Multi-modality Data Integration Deciphers Tertiary Lymphoid Structure Maturity in Gastric Cancer.
   Cancer Res. 2025 Oct 28. doi: 10.1158/0008-5472.CAN-25-1793.
   

   >> Share

   
   
7. WANG Q, Zhong L, Wang X, Zhang Z, et al
   RORgamma Hijacks HIF-1alpha to Promote Peritoneal Metastasis of Gastric Cancer.
   Cancer Res. 2025 Oct 23. doi: 10.1158/0008-5472.CAN-25-1690.
   

   >> Share

   
   
8. XU Y, Ye Z, Lin Z, Qian X, et al
   Disrupting Paraspeckle Stability by Targeting WTX-NONO Phase Separation Enhances Chemotherapy Efficacy in Gastric Cancer.
   Cancer Res. 2025 Oct 20. doi: 10.1158/0008-5472.CAN-25-1747.
   

   >> Share

   
   September 2025
9. KIM J, Shrestha C, Lee G, Jung D, et al
   Condensation of the Golgi Apparatus Activates YAP1 to Promote Gastric Cancer Progression.
   Cancer Res. 2025 Sep 8. doi: 10.1158/0008-5472.CAN-24-3920.
   

   >> Share

   
   August 2025
10. CONTICELLI D, Volante M, Pietrantonio F, Orru C, et al
    AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.
    Cancer Res. 2025;85:3111-3122.
    

    >> Share

    
    May 2025
11. XU X, Yan C, Bian L, Li Z, et al
    Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer.
    Cancer Res. 2025 May 16. doi: 10.1158/0008-5472.CAN-24-4065.
    

    >> Share

    
    
12. KUAI X, Li L, Chen R, Wang K, et al
    Correction: SCFFBXW7/GSK3beta-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.
    Cancer Res. 2025;85:1739.
    

    >> Share

    
    April 2025
13. QIU B, Zheng Y, Liu S, Song R, et al
    Multi-task Deep Learning Based on Longitudinal CT Images Facilitates Prediction of Lymph Node Metastasis and Survival in Chemotherapy-Treated Gastric Cancer.
    Cancer Res. 2025 Apr 30. doi: 10.1158/0008-5472.CAN-24-4190.
    

    >> Share

    
    March 2025
14. LIN GT, Yan C, Li LJ, Qiu XW, et al
    Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy.
    Cancer Res. 2025 Mar 7. doi: 10.1158/0008-5472.CAN-24-2697.
    

    >> Share

    
    February 2025
15. ZHANG T, Li Y, Zhai E, Zhao R, et al
    Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2580.
    

    >> Share

    
    October 2024
16. CUI Y, Chang Y, Ma X, Sun M, et al
    Ephrin A1 Stimulates CCL2 Secretion to Facilitate Pre-metastatic Niche Formation and Promote Gastric Cancer Liver Metastasis.
    Cancer Res. 2024 Oct 16. doi: 10.1158/0008-5472.CAN-24-1254.
    

    >> Share

    
    July 2024
17. LIU X, Chen B, Xie F, Wong KY, et al
    FOXP4 is a Direct YAP1 Target that Promotes Gastric Cancer Stemness and Drives Metastasis.
    Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3074.
    

    >> Share

    
    
18. LIU S, Lin C, Lin X, Lin P, et al
    NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression.
    Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-23-4062.
    

    >> Share

    
    
19. GNANAPRAGASAM A, Kirbizakis E, Li A, White KH, et al
    HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer.
    Cancer Res. 2024;84:2377-2389.
    

    >> Share

    
    December 2023
20. TU RH, Wu SZ, Huang ZN, Zhong Q, et al
    Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.
    Cancer Res. 2023;83:3868-3885.
    

    >> Share

    
    September 2023
21. FAN Y, Song S, Li Y, Dhar SS, et al
    Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases.
    Cancer Res. 2023 Sep 22. doi: 10.1158/0008-5472.CAN-23-0783.
    

    >> Share

    
    August 2023
22. YE H, Shi W, Yang J, Wang L, et al
    PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
    Cancer Res. 2023 Aug 30. doi: 10.1158/0008-5472.CAN-23-1331.
    

    >> Share

    
    May 2023
23. PETRELLI A, Rizzolio S, Pietrantonio F, Bellomo SE, et al
    BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
    Cancer Res. 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.
    

    >> Share

    
    March 2023
24. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2023;83:804.
    

    >> Share

    
    
25. TAURIELLO DVF
    Targeting CAFs to Improve Anti-PD-1 Checkpoint Immunotherapy.
    Cancer Res. 2023;83:655-656.
    

    >> Share

    
    
26. AKIYAMA T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, et al
    Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
    Cancer Res. 2023;83:753-770.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share